Immatics
gen in phase a dose bor and response over time | Immatics
Company
Deck Type
Sector
Industry
Deck date
November 2023
Slide
71 of 75
Related slides by other companies
AstraZeneca
Investor Day
June 2022
in advanced renal cell carcinoma | AstraZeneca
Genprex
Investor Presentation
November 2024
phase dose in relapsed patients | Genprex
Ocuphire Pharma
Investor Day
January 2022
mean pupil diameter over time a | Ocuphire Pharma
Arbutus Biopharma
Results
November 2022
phase a clinical trial single ascending dose | Arbutus Biopharma
Other recent decks by Immatics
See all presentations (2 decks)
Results
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights